In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cosmederm-7 "substantially reduces" AHA irritation, company chief says.

This article was originally published in The Rose Sheet

Executive Summary

COSMEDERM-7 ANTI-IRRITANT "SUBSTANTIALLY REDUCES" AHA IRRITATION, making it possible to formulate "very high efficacy" alpha hydroxy products without side effects that are unacceptable to the consumer, Cosmederm Technologies President and Chief Technical Officer Gary Hahn, MD, said at a June 11 seminar at the HBA Global Expo in New York City. Cosmederm-7 is "a potent and selective inhibitor of sting, burn and itch for cosmetics" that "offers highly effective, long duration anti-irritant activity against a wide variety of chemical ingredients" found in AHA products, antiperspirants, anti-acne agents and depilatories, according to the company. Privately held Cosmederm Technologies, headquartered in La Jolla, Calif., "develops and commercializes innovative neurosensory-based technologies for the cosmetics, personal care and pharmaceutical industries," the firm said.



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts